ProEncia Biotechnology Nabs Pre-Seed Funding

ProEncia Biotechnology, a Minnesota-based startup, closed a notable pre-seed round.

The company will use the funds to advance a pipeline of periodontal care products.

Its planned offerings include preventive and therapeutic options for gingivitis and periodontitis.

The funding supports commercialization of non-invasive treatments for gum disease.